| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000270605.1 |
Ponatinib |
Brain lower grade glioma |
0.011099676 |
Resistant |
| ENSG00000270605.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.010757916 |
Resistant |
| ENSG00000270605.1 |
Ponatinib |
Sarcoma |
0.024178247 |
Sensitive |
| ENSG00000270605.1 |
Ponatinib |
Brain lower grade glioma |
0.048558364 |
Resistant |
| ENSG00000270605.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.016579122 |
Resistant |
